Breast Cancer BRCA1 Carriers: a Pilot Study
Status: WITHDRAWN
Study type: OBSERVATIONAL
Conditions: BRCA1 Mutation|High-grade Serous Ovarian Cancer|TNBC - Triple-Negative Breast Cancer
Interventions: DRUG: Mifepristone 200 MG|PROCEDURE: Prophylactic mastectomy
Sponsor: Indiana University
Collaborators: Breast Cancer Research Foundation